Stock listing

EPRX Stock Price, News, Filings & Events — Eupraxia Pharmaceuticals, Inc.

Selected listing: EPRX · NASDAQ · USD · US

EPRX:NASDAQ represents Eupraxia Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for pain management and other conditions. The company is advancing its lead product candidate, which aims to improve patient outcomes in the treatment of osteoarthritis and other musculoskeletal disorders. Recent news highlights Eupraxia's progress in clinical trials and its commitment to addressing unmet medical needs in the pharmaceutical market. Investors can find the latest filings and updates on upcoming events related to the company's development efforts.

EPRX:NASDAQUSDUSUpdated July 21, 2026
Eupraxia Pharmaceuticals, Inc. logo
Ticker
EPRX:NASDAQ
Asset type
Stock
Market cap
$403.6M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Eupraxia Pharmaceuticals, Inc. EPRX:NASDAQ stock context

EPRX:NASDAQ represents Eupraxia Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for pain management and other conditions. The company is advancing its lead product candidate, which aims to improve patient outcomes in the treatment of osteoarthritis and other musculoskeletal disorders. Recent news highlights Eupraxia's progress in clinical trials and its commitment to addressing unmet medical needs in the pharmaceutical market. Investors can find the latest filings and updates on upcoming events related to the company's development efforts.

Research Eupraxia Pharmaceuticals, Inc.

Alternate listings